Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial

Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial

<p><strong>Aims</strong></p> <p>To evaluate 1,5‐anhydroglucitol (1,5‐AG) according to clinical outcomes and assess the effects of glucose‐ and blood pressure‐lowering interventions on change in 1,5‐AG levels in people with type 2 diabetes.</p> <p><strong...

書誌詳細
主要な著者:	Selvin, E, Wang, D, McEvoy, JW, Juraschek, SP, Lazo, M, Hamet, P, Cooper, ME, Marre, M, Williams, B, Harrap, S, Chalmers, J, Woodward, M
フォーマット:	Journal article
言語:	English
出版事項:	Wiley 2019

類似資料

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
著者:: Rahman, F, 等
出版事項: (2019)

Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism
著者:: Man Li, 等
出版事項: (2017-06-01)

Data for serum 1,5 anhydroglucitol concentration in different populations
著者:: Marciane Welter, 等
出版事項: (2018-10-01)

The clinical potential of 1,5-anhydroglucitol as biomarker in diabetes mellitus
著者:: Haiying Xu, 等
出版事項: (2024-10-01)

The Use of 1.5-Anhydroglucitol for Monitoring Glycemic Control in Islet Transplant Recipients
著者:: Eduardo Moraes Leao Peixoto, 等
出版事項: (2014-10-01)

The use of 1,5 anhydroglucitol level as a clinical test to differentiate subtypes of diabetes
著者:: Owen, K, 等
出版事項: (2009)

Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial
著者:: Ohkuma, T, 等
出版事項: (2019)

Pemeriksaan 1,5-Anhydroglucitol, Suatu Hal Baru dalam Pemeriksaan Prediabetes
著者:: Reza Febryan
出版事項: (2024-03-01)

Value of serum 1,5-anhydroglucitol measurements in childhood obesity in the continuum of diabetes
著者:: Ha Yeong Yoo, 等
出版事項: (2015-12-01)

The progress of clinical research on the detection of 1,5-anhydroglucitol in diabetes and its complications
著者:: Huijuan Xu, 等
出版事項: (2024-05-01)

Side-effects and tolerability of combination blood pressure lowering according to blood pressure levels – an analysis of the PROGRESS and ADVANCE trials
著者:: Atkins, A, 等
出版事項: (2017)

Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.
著者:: Pal, A, 等
出版事項: (2010)

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
著者:: Kamel Mohammedi, 等
出版事項: (2021-01-01)

Prognostic Value of Serum 1,5-anhydroglucitol Levels in Patients with Acute Myocardial Infarction
著者:: Yijia Wang, 等
出版事項: (2022-12-01)

Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance
著者:: Thyparambil Aravindakshan Pramodkumar, 等
出版事項: (2016-01-01)

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
著者:: Zoungas, S, 等
出版事項: (2009)

1,5-anhydroglucitol in diabetes: its role in diagnostics, screening, glycemic status assessment, and the prediction of complications
著者:: V. V. Klimontov, 等
出版事項: (2020-08-01)

Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol
著者:: Ji-Eun Lee
出版事項: (2015-06-01)

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
著者:: Patel, A, 等
出版事項: (2008)

Lowering blood pressure reduces renal events in type 2 diabetes.
著者:: de Galan, B, 等
出版事項: (2009)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
著者:: Perkovic, V, 等
出版事項: (2013)

1,5-anhydroglucitol is a good predictor for the treatment effect of the Sodium-Glucose cotransporter 2 inhibitor in Japanese patients with type 2 diabetes mellitus
著者:: Masahiro Usui, 等
出版事項: (2020-09-01)

Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study
著者:: Rådholm, K, 等
出版事項: (2018)

Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome
著者:: Gong Su, 等
出版事項: (2020-05-01)

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
著者:: Woodward, M, 等
出版事項: (2016)

Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis
著者:: Kenji Tanaka, 等
出版事項: (2021-08-01)

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
著者:: Mohammedi, K, 等
出版事項: (2016)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
著者:: Mohammedi, K, 等
出版事項: (2017)

Saliva 1,5-anhydroglucitol is associated with early-phase insulin secretion in Chinese patients with type 2 diabetes
著者:: Jian Zhou, 等
出版事項: (2021-03-01)

1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
著者:: Hannah Seok, 等
出版事項: (2015-04-01)

Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy
著者:: Luiza Cristina Gobor, 等
出版事項: (2021-10-01)

Detection of 1,5-anhydroglucitol as a Biomarker for Diabetes Using an Organic Field-Effect Transistor-Based Biosensor
著者:: Hiroyuki Furusawa, 等
出版事項: (2018-08-01)

Human and mouse non‐targeted metabolomics identify 1,5‐anhydroglucitol as SGLT2‐dependent glycemic marker
著者:: Ben A. Kappel, 等
出版事項: (2021-06-01)

Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes
著者:: Yun Shen, 等
出版事項: (2020-01-01)

Nonlinear association of 1,5-anhydroglucitol with the prevalence and severity of coronary artery disease in chinese patients undergoing coronary angiography
著者:: Ruiyue Yang, 等
出版事項: (2022-09-01)

Evaluation of serum 1,5-anhydroglucitol levels as hyperglycemic indicator in patients with newly diagnosed type 2 diabetes mellitus
著者:: Ashok Vanagamudi, 等
出版事項: (2022-01-01)

Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes
著者:: Mohammedi, K, 等
出版事項: (2016)

The relationship between serum 1,5-anhydroglucitol and adverse outcomes in acute coronary syndrome with and without chronic kidney disease patients
著者:: Yijia Wang, 等
出版事項: (2024-07-01)

1,5-Anhydroglucitol promotes pre-B acute lymphocytic leukemia progression by driving glycolysis and reactive oxygen species formation
著者:: Huasu Zhu, 等
出版事項: (2023-02-01)

The impact of level of education on vascular events and mortality in patients with type 2 Diabetes mellitus: results from the ADVANCE study
著者:: Blomster, J, 等
出版事項: (2017)